SNT
Click for more information
7.89% 4.1¢ syntara limited

I recall reading in an early interview that Pharmaxis considered...

  1. gliontos
    1,300 Posts.
    lightbulb Created with Sketch. 69
    clock Created with Sketch.
    16/04/05
    23:12
    Post #: 874008
    I recall reading in an early interview that Pharmaxis considered that the therapeutic/autoimmune market in OZ was very fragmented and that they would consider taking over companies if they fit the mold.

    PXS Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
NEWS Capital raisings wrap: Brainchip, Ovanti, Lake and VHM
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.1¢ 		Change
0.003(7.89%) 		Mkt cap ! $48.95M
Open High Low Value Volume
3.8¢ 4.1¢ 3.6¢ $42.31K 1.111M

Buyers (Bids)

No. Vol. Price($)
1 100000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 149088 1
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.